LBA61 Durvalumab (durva) after sequential chemoradiotherapy (CRT) in patients (pts) with unresectable stage III NSCLC: Final analysis from PACIFIC-6
Saved in:
| Published in: | Annals of oncology Vol. 34; pp. S1301 - S1302 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Elsevier Ltd
01-10-2023
|
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Author | Mansy, T. Bernabe Caro, R. García Sanchez, J. Bischoff, H. Garassino, M.C. Reinmuth, N. Chara Velarde, L.E. Reck, M. Faivre-Finn, C. Migliorino, M.R. Diaz Perez, I. Mazieres, J. Paz-Ares, L. Chander, P. Cortinovis, D.L. Chouaid, C. Foroutanpour, K. Delmonte, A. Cove-Smith, L.S. |
|---|---|
| Author_xml | – sequence: 1 givenname: M.C. surname: Garassino fullname: Garassino, M.C. organization: Department of Medicine - Hematology and Oncology, University of Chicago, Chicago, IL, USA – sequence: 2 givenname: J. surname: Mazieres fullname: Mazieres, J. organization: Thoracic Oncology, Institut Universitaire du Cancer de Toulouse, Toulouse, France – sequence: 3 givenname: M. surname: Reck fullname: Reck, M. organization: Department of Thoracic Oncology, Lung Clinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany – sequence: 4 givenname: C. surname: Chouaid fullname: Chouaid, C. organization: Service de Pneumologie, Centre Hospitalier Intercommunal de Créteil, Créteil, France – sequence: 5 givenname: H. surname: Bischoff fullname: Bischoff, H. organization: Thoraxklinik Heidelberg, Universitätsklinikum Heidelberg, Heidelberg, Germany – sequence: 6 givenname: N. surname: Reinmuth fullname: Reinmuth, N. organization: Thoracic Oncology, Asklepios Fachkliniken München-Gauting, and German Center for Lung Research (DZL), Gauting, Germany – sequence: 7 givenname: L.S. surname: Cove-Smith fullname: Cove-Smith, L.S. organization: Department of Medical Oncology – Lung, The Christie NHS Foundation Trust and Manchester University Hospitals Foundation Trust, Manchester, UK – sequence: 8 givenname: T. surname: Mansy fullname: Mansy, T. organization: Department of Oncology, James Cook University Hospital, Middlesbrough, UK – sequence: 9 givenname: D.L. surname: Cortinovis fullname: Cortinovis, D.L. organization: Medical Oncology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy – sequence: 10 givenname: M.R. surname: Migliorino fullname: Migliorino, M.R. organization: Oncology, San Camillo-Forlanini Hospital, Rome, Italy – sequence: 11 givenname: A. surname: Delmonte fullname: Delmonte, A. organization: Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori” (IRST), Meldola, Italy – sequence: 12 givenname: J. surname: García Sanchez fullname: García Sanchez, J. organization: Medical Oncology, Hospital Arnau de Vilanova, Fundación para el Fomento de la Investigación Sanitaria i Biomédica de la Comunidad Valenciana (FISABIO), Valencia, Spain – sequence: 13 givenname: L.E. surname: Chara Velarde fullname: Chara Velarde, L.E. organization: Medical Oncology, Hospital Universitario de Guadalajara, Guadalajara, Spain – sequence: 14 givenname: R. surname: Bernabe Caro fullname: Bernabe Caro, R. organization: Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain – sequence: 15 givenname: L. surname: Paz-Ares fullname: Paz-Ares, L. organization: Oncology, Universidad Complutense, CiberOnc, CNIO and Hospital Universitario 12 de Octubre, Madrid, Spain – sequence: 16 givenname: P. surname: Chander fullname: Chander, P. organization: Global Medical Affairs, AstraZeneca, Gaithersburg, MD, USA – sequence: 17 givenname: I. surname: Diaz Perez fullname: Diaz Perez, I. organization: Global Medical Affairs, AstraZeneca, Gaithersburg, MD, USA – sequence: 18 givenname: K. surname: Foroutanpour fullname: Foroutanpour, K. organization: Global Medical Affairs, AstraZeneca, Gaithersburg, MD, USA – sequence: 19 givenname: C. surname: Faivre-Finn fullname: Faivre-Finn, C. organization: Division of Cancer Sciences, and Clinical Oncology, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK |
| BookMark | eNp9kMFu2zAMhoWiA5qme4MeeEwO9iRblqMeCqTushoI2mHrzgYt042CxE4lJ0PeYw88Bem5F5L4Qf7g_12zy67viLFbwWPBhfq2jrELkokTnqRBinmWX7CRyJSOZlyKSzbiOkmjPEvlFbv2fs05VzrRI_Zv-TBXAh737oCb_RZrmDSneQrYDuTA0_ueusHiBsyKtr3DxvbDihzujjApfr1OwXaww8GGLQ-T3eCn8NcOK9h3jjyZAesNgR_wjaAsS3j-XSyLO1jYLlhiKEdvPbSu38LPeVEuyiJSN-xLixtPXz_6mP1ZfH8tnqLly4-ymC8jI3SeRzKtpZzNVI2tNhpxlqQqy7loeJslrc5rmWfUGKl03XJhJKVNrSU3SSIV5RmmYybPvsb13jtqq52zW3THSvDqRLZaV2ey1YnsSQ1kw9n9-YzCbwdLrvImxDfUWBcCV01vPzf4D_EBhMs |
| CitedBy_id | crossref_primary_10_1016_j_ctrv_2024_102797 |
| ContentType | Journal Article |
| Copyright | 2023 European Society for Medical Oncology |
| Copyright_xml | – notice: 2023 European Society for Medical Oncology |
| DBID | AAYXX CITATION |
| DOI | 10.1016/j.annonc.2023.10.057 |
| DatabaseName | CrossRef |
| DatabaseTitle | CrossRef |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1569-8041 |
| EndPage | S1302 |
| ExternalDocumentID | 10_1016_j_annonc_2023_10_057 S0923753423042011 |
| GroupedDBID | --- -E4 .2P .86 .I3 .XZ .ZR 08P 0R~ 0U7 1TH 23M 2WC 4.4 482 48X 53G 5GY 5VS 5WA 6.Y 6J9 70D AABJS AABMN AAEDW AAESY AAIAV AAIYJ AAJKP AAJQQ AAKAS AAKUH AAMVS AAOGV AAPNW AAUQX AAXUO ABEUO ABIXL ABJNI ABKDP ABLJU ABNKS ABOCM ABQLI ABQTQ ABSAR ABSMQ ABVKL ABZBJ ACGFO ACGFS ACIMA ACMRT ACPQN ACPRK ACUFI ACUTO ADBBV ADEIU ADEYI ADHKW ADHZD ADJQC ADOCK ADORX ADQLU ADRIX ADRTK ADYVW ADZCM ADZXQ AEGPL AEGXH AEJOX AEKPW AEKSI AEMDU AENEX AENZO AEPUE AEWNT AFIYH AFOFC AFXEN AGINJ AGKEF AGKRT AGSYK AHMBA AHXPO AIAGR AIJHB AIKOY AITUG ALMA_UNASSIGNED_HOLDINGS ALUQC AMRAJ APIBT APWMN AQKUS ASMCH ASPBG ATTQO AVWKF AWCFO AXUDD AZFZN AZQFJ BAWUL BAYMD BEYMZ BGNMA BGYMP BHONS BTRTY BVRKM BZKNY C1A CAG CASEJ CDBKE CKLRP COF CS3 CZ4 DAKXR DIK DILTD DL5 DPORF DPPUQ D~K E3Z EBS EE~ EJD EX3 F9B FDB FEDTE GJXCC GX1 H5~ HAR HVGLF HW0 HZ~ I09 IH2 IHE IOX J21 KAQDR KC5 KDC KOM KOP KQ8 KSI KSN LAK M-Z M41 M49 M4Y MBLQV MHKGH N9A NCXOZ NGC NOYVH NTWIH NU- NU0 NVLIB O9- OAWHX ODMLO OJQWA OK1 OVD P2P P6G PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RNI ROL ROX ROZ RPX RW1 RXO RZC RZE RZF RZO SDH TCURE TEORI TJX TMA TR2 U2A W8F WOQ WOW X7H YAYTL YFH YKOAZ ZKX ZXP ~91 AALRI AAYXX ADVLN AEHUL AFETI AFJKZ AFSHK AKRWK CITATION H13 |
| ID | FETCH-LOGICAL-c1977-43b44886baf9c9aa82365701d0f52f97b475edc469bf01c4e3db940c2246e75a3 |
| ISSN | 0923-7534 |
| IngestDate | Fri Nov 22 01:52:14 EST 2024 Fri Feb 23 02:35:46 EST 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c1977-43b44886baf9c9aa82365701d0f52f97b475edc469bf01c4e3db940c2246e75a3 |
| OpenAccessLink | https://doi.org/10.1016/j.annonc.2023.10.057 |
| ParticipantIDs | crossref_primary_10_1016_j_annonc_2023_10_057 elsevier_sciencedirect_doi_10_1016_j_annonc_2023_10_057 |
| PublicationCentury | 2000 |
| PublicationDate | October 2023 2023-10-00 |
| PublicationDateYYYYMMDD | 2023-10-01 |
| PublicationDate_xml | – month: 10 year: 2023 text: October 2023 |
| PublicationDecade | 2020 |
| PublicationTitle | Annals of oncology |
| PublicationYear | 2023 |
| Publisher | Elsevier Ltd |
| Publisher_xml | – name: Elsevier Ltd |
| SSID | ssj0006929 |
| Score | 2.475007 |
| SourceID | crossref elsevier |
| SourceType | Aggregation Database Publisher |
| StartPage | S1301 |
| Title | LBA61 Durvalumab (durva) after sequential chemoradiotherapy (CRT) in patients (pts) with unresectable stage III NSCLC: Final analysis from PACIFIC-6 |
| URI | https://dx.doi.org/10.1016/j.annonc.2023.10.057 |
| Volume | 34 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELe6ISFeEJ9iDJAfeGhVJcqnnfBWshYC24RokXiLEttBHVo2dc0Lfwd_MHe20wQ2IUDiJWosJ3Fzv96dr3e_I-RlFYukYnHseEwgqbYQTsIkd7iIlJSejBTXTWyX_PRzcjSP5qNR1zi1H_uvkoYxkDVWzv6FtHc3hQH4DDKHI0gdjn8k9-PXM-ZPj9oN0niflxW6kBLPcP9vOoKb9OktxspBZOcAArm2hVj6v__s4won96yrOjJ7iQkXqQnctpokSGx13RX4l1_UNM_z6ekyO84wxrDQvbbKjvBE17B8mGX5Is8cNvSHe_7mi0b8FOF_U27Ar1_rzuDTEzdz-9j5NzDlRru9242C-_vVzOwTFi7acq0BbC-2wY2gT5OzEbeu6qZPcdKhS5gI2ywTiFBWcbPUQS6loWa3M4xqXoK19gd2Hs-DG42IiWecuWXTwHd3cV0uZgAaJu1f6LmXuBpcDEbX0ZvaI7cCUHp6e5-_33kFLA0M76Nde1fGqXMNrz_pZjdp4Pqs7pG7ds9CZwZs98lINQ_I7ROblfGQfNeYoz3m6FgjbkI13miPN3oNb3QMaJvQdUM7rNExIG1CEWd0iDOqcUYBZ1Tj7BXVKKMdyiiijO5Q9oh8WsxX2VvHdvtwhA-bECcKqwisCavKOhVpWSZBiGlZvvTqOKhTXkU8VlJELK1qzwdVEsoqjTyBjIiKx2X4mOzDW1RPCAVTIkPuyTpORMQDlcRwcz-sGPJlgoE6IE73cotLQ-pSdNmOZ4URRoHCwFEQxgHhnQQK65gah7MAyPz2yqf_fOUhudP_IJ6R_e2mVc_J3pVsX2hg_QBbraqm |
| link.rule.ids | 315,782,786,27933,27934 |
| linkProvider | Flying Publisher |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=LBA61+Durvalumab+%28durva%29+after+sequential+chemoradiotherapy+%28CRT%29+in+patients+%28pts%29+with+unresectable+stage+III+NSCLC%3A+Final+analysis+from+PACIFIC-6&rft.jtitle=Annals+of+oncology&rft.au=Garassino%2C+M.C.&rft.au=Mazieres%2C+J.&rft.au=Reck%2C+M.&rft.au=Chouaid%2C+C.&rft.date=2023-10-01&rft.pub=Elsevier+Ltd&rft.issn=0923-7534&rft.eissn=1569-8041&rft.volume=34&rft.spage=S1301&rft.epage=S1302&rft_id=info:doi/10.1016%2Fj.annonc.2023.10.057&rft.externalDocID=S0923753423042011 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0923-7534&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0923-7534&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0923-7534&client=summon |